Transgene delivery of plasmid DNA to smooth muscle cells and macrophages from a biostable polymer-coated stent

Gene Therapy

Volumn 10, Issue 17, 2003, Pages 1471-1478

  Takahashi, A ^a,b   Palmer Opolski, M ^c   Smith, R C ^a,b   Walsh, K ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Surface Solutions Labs Inc   (United States)

Author keywords

Experimental; Macrophages; Restenosis; Smooth muscle; Stents; Vasculature

Indexed keywords

BETA GALACTOSIDASE; GREEN FLUORESCENT PROTEIN; LUCIFERASE; METAL; PACLITAXEL; PLASMID DNA; POLYMER; POLYURETHAN; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; EMULSION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; ILIAC ARTERY; IMMUNOCOMPETENT CELL; IMPLANT; LIVER; LUNG; MACROPHAGE; MALE; MARKER GENE; MATERIAL COATING; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RABBIT; RESTENOSIS; SMOOTH MUSCLE FIBER; SPLEEN; STENT; TRANSGENE;

ANIMALS; BETA-GALACTOSIDASE; CAROTID ARTERIES; CELLS, CULTURED; DNA; GENE EXPRESSION; GENE THERAPY; GREEN FLUORESCENT PROTEINS; LUCIFERASES; LUMINESCENT PROTEINS; MACROPHAGES; MALE; MICROSCOPY, FLUORESCENCE; MUSCLE, SMOOTH; POLYURETHANES; RABBITS; STENTS; TRANSFECTION; TRANSGENES;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0042526004     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302010     Document Type: Article

References (30)

1. Topol EJ. Coronary-artery stents - gauging, gorging, and gouging. N Engl J Med 1998; 339: 1702-1704.
2. Fischman DL et al. A randomized comparison of coronary-stent-placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 469-501.
3. Serruys P et al. A comparison of balloon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-495.
4. Kornowski R et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998; 31: 224-230.
5. Lincoff A, Furst J, Ellis S, Tuch R et al. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 1997; 29: 808-816.
6. Karas S et al. Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis. J Am Coll Cardiol 1992; 20: 467-474.
7. Kearney M et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation 1997; 95: 1998-2002.
8. Drachman D et al. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol 2000; 36: 2325-2332.
9. Farb A et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 2001; 104: 473-479.
10. Suzuki T et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104: 1188-1193.
11. Sousa J et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104: 2007-2011.
12. Sousa J et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001; 103: 192-195.
13. Sata M et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8: 403-409.
14. Klugherz BD et al. Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat Biotechnol 2000; 18: 1181-1184.
15. Horvath C et al. Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted. Circ Res 2002; 90: 488-494.
16. Feldman LJ et al. Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation 2000; 101: 908-916.
17. Kollum M et al. Apoptosis after stent implantation compared with balloon angioplasty in rabbits. Role of macrophage. Arterioscler Thromb Vasc Biol 1997; 17: 2382-2388.
18. Rogers C, Edelman ER, Simon DI. A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci USA 1998; 95: 10134-10139.
19. Van der Giessen W et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996; 94: 1690-1697.
20. De Scheerder I et al. Biocompatibility of polymer-coated over-sized metallic stents implanted in normal porcine coronary arteries. Atherosclerosis 1995; 114: 105-114.
21. Smith RC, Walsh K. Gene therapy for restenosis. Curr Cardiol Rep 2000; 2: 13-23.
22. Smith R, Walsh K. Local gene delivery to the vessel wall. Acta Physiol Scand 2001; 173: 93-102.
23. Sata M et al. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc Natl Acad Sci USA 1998; 95: 1213-1217.
24. Luo Z et al. Adenovirus-mediated delivery of Fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals. Circulation 1999; 99: 1776-1779.
25. Newman KD et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cellactivation, inflammation, and neointimal hyperplasia. J Clin Invest 1995; 96: 2955-2965.
26. Palasis M, Luo Z, Barry JJ, Walsh K. Analysis of adenoviral transport mechanisms in the vessel wall and optimization of gene transfer using local devices. Hum Gene Ther 2000; 11: 237-246.
27. Simari RD et al. Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. J Clin Invest 1996; 98: 225-235.
28. Marx SO, Jayaraman T, Go LO, Marks AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 1995; 76: 412-417.
29. Poon M et al. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 1996; 98: 2277-2283.
30. Lim CS et al. Direct in vivo gene transfer into the coronary artery and peripheral vasculature of the intact dog. Circulation 1991; 83: 2007-2011.